Several investigations indicate that EGFR and HER-2 experience coamplification in numerous cancer types, including those of the breast, ovaries, prostate, colon, and other tissues (Alkahtani et al., 2020; Luhtala, 2019; Maennling et al., 2019). This evidence concerns the gene ERBB2 and cancer.